ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 357 filers reported holding ISIS PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 1.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $6,511,000 | -54.7% | 161,076 | -35.4% | 0.15% | -43.1% |
| Q2 2015 | $14,360,000 | -35.3% | 249,529 | -28.4% | 0.27% | -27.2% |
| Q1 2015 | $22,195,000 | +109.6% | 348,598 | +103.2% | 0.37% | +125.2% |
| Q4 2014 | $10,590,000 | -48.0% | 171,531 | -67.3% | 0.16% | -40.5% |
| Q3 2014 | $20,357,000 | -28.8% | 524,247 | -36.8% | 0.27% | -17.5% |
| Q2 2014 | $28,583,000 | -23.7% | 829,698 | -4.3% | 0.33% | -22.6% |
| Q1 2014 | $37,474,000 | – | 867,252 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,417,548 | $255,675,000 | 13.66% |
| HWG Holdings LP | 339,799 | $13,538,000 | 8.73% |
| DOWLING & YAHNKE LLC | 675,798 | $26,924,000 | 3.78% |
| GARRISON BRADFORD & ASSOCIATES INC | 99,300 | $3,956,000 | 3.74% |
| WILLIAM HARRIS INVESTORS INC | 283,834 | $11,308,000 | 3.35% |
| SECTORAL ASSET MANAGEMENT INC | 1,222,401 | $48,700,000 | 2.10% |
| AVALON CAPITAL MANAGEMENT | 49,999 | $1,992,000 | 1.68% |
| PINNACLE ASSOCIATES LTD | 2,016,369 | $80,332,000 | 1.57% |
| PERKINS CAPITAL MANAGEMENT INC | 48,515 | $1,933,000 | 1.30% |
| NCM Capital Advisers, Inc. | 31,100 | $1,239,000 | 1.28% |